Skip to main content

Stem Cell Banking Market to Surpass Value of USD 18.65 Billion By 2031 | SkyQuest Technology

The stem cell banking market is growing due to advancements in cryopreservation, cell bank prep, monoclonal antibodies, and the rising adoption of stem cell therapy. Westford, USA, Dec. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global stem cell banking market share will reach a value of USD 18.65 Billion by 2031, with a CAGR of 18.30% during the forecast period (2024-2031). As cryopreservation and cell bank preparation techniques are getting advanced, the stem cell banking market is expanding rapidly. Besides, the market is growing due to the increased application of stem cell treatment and the trend of monoclonal antibodies with effective biopharmaceuticals. Furthermore, with the fact that more couples are opting for children at a later stage in life, late parenting is on the rise, and it has generated interest in...

Continue reading

Pharming announces public cash offer to the shareholders of Abliva AB

Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset Abliva’s lead product KL1333 is currently in a pivotal clinical trial, with a positive interim analysis achieved, in mitochondrial DNA-driven primary mitochondrial diseases Total transaction value of approximately US$66.1 million No external funding required to fund acquisition and KL1333 development costs Pharming to host a conference call on Monday, December 16, 2024 at 14:00 CET (8:00 am EST) Leiden, the Netherlands, December 15, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced a recommended public cash offer to the shareholders of Abliva AB (“Abliva”) to acquire all issued and outstanding shares of Abliva. Pharming, through its wholly-owned subsidiary Pharming Technologies...

Continue reading

Alpha Modus and Insight Acquisition Corp Close Business Combination and Alpha Modus will Begin Trading Under “AMOD” Ticker

CORNELIUS, N.C. and NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) —  Alpha Modus Holdings, Inc. (“Alpha Modus” or the “Company”), a technology company with a core focus on artificial intelligence in retail, is pleased to announce that the business combination between Insight Acquisition Corp. and Alpha Modus Corp. has closed, and Alpha Modus’s common stock and warrants will begin trading on the Nasdaq Global Market under the ticker symbols “AMOD” and “AMODW”, respectively, on Monday, December 16, 2024. In connection with the closing of the business combination, the combined company consummated and issued a secured convertible promissory note to an investor, in exchange for net proceeds of approximately $2.6 million, which will be used primarily to cover transaction costs and for working capital. The structure of the financing...

Continue reading

Fairfax Announces Acquisition of OMERS Investment in Brit

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has increased its ownership interest in Brit Limited to 100% from 86.2% by acquiring the interest of OMERS, the pension plan for Ontario’s municipal employees, for cash consideration of approximately US$383 million. Fairfax is a holding company which, through its subsidiaries, is primarily engaged in property and casualty insurance and reinsurance and the associated investment management. For further information contact:        John Varnell, Vice President, Corporate Development at (416) 367-4941

Continue reading

Rogers Provides Update on Its Acquisition of Bell’s 37.5% Stake in MLSE

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) — Rogers Communications (TSX: RCI.A and RCI.B) (NYSE: RCI) today announced it has received clearance from the Competition Bureau to proceed with the acquisition of Bell’s 37.5% stake in Maple Leaf Sports & Entertainment. Rogers and Bell received a “no-action letter” on December 12, 2024, from the Bureau, indicating that the Commissioner of Competition does not intend to challenge Rogers acquisition of Bell’s interest in MLSE. The deal is subject to league approvals and approval from the CRTC. “This reflects an important step in securing approvals and expanding our ownership of MLSE, one of the most prestigious sports and entertainment organizations in the world,” said Tony Staffieri, President and CEO, Rogers. “As Canada’s leading communications and entertainment company,...

Continue reading

AleAnna, Inc. Announces Completion of Business Combination between Swiftmerge Acquisition Corp. and AleAnna Energy, LLC

AleAnna Accelerates Efforts to Improve Italy’s Energy Sustainability and Security with Strategic Business CombinationCombination brings emerging leader in Italian natural gas and renewable natural gas to public markets Shares of AleAnna, Inc. to begin trading on Nasdaq on December 16 under the ticker symbol “ANNA” AleAnna stands on the cusp of a major milestone, with the first phase of natural gas production from the Longanesi Field projected to commence in Q1 2025DALLAS and VANCOUVER, British Columbia and ROME, Dec. 13, 2024 (GLOBE NEWSWIRE) — AleAnna, Inc. (together with its subsidiaries, “AleAnna” or the “Company”), an emerging leader in Italy’s energy landscape, announced the completion of the previously announced business combination (the “Business Combination”) between Swiftmerge Acquisition Corp. (NASDAQ: IVCP) (“Swiftmerge”),...

Continue reading

Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million

        Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating serious, rare genetic diseases Strong balance sheet with approximately $80.0 million of cash and cash equivalents, including proceeds from a PIPE financing co-led by BVF Partners, L.P. and Frazier Life Sciences Cash expected to fund operations into the second half of 2027, including through Phase 3 SELVA clinical trial of QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of microcystic lymphatic malformations (microcystic LMs) and Phase 2 clinical trial in cutaneous venous malformations (cutaneous VMs) Microcystic LMs is a chronically debilitating and lifelong genetic disease affecting an estimated...

Continue reading

Alpha Modus Plans to Close Business Combination With Insight Acquisition Corp. Today and Expects to Begin Trading on Monday Under “AMOD” Ticker

CORNELIUS, N.C. and NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) —  Alpha Modus Corp. (“Alpha Modus” or the “Company”), a technology company with a core focus on artificial intelligence in retail, and Insight Acquisition Corp., a special purpose acquisition company (“Insight” NASDAQ: INAQ) plan to close their business combination today. Alpha Modus expects to begin trading on the Nasdaq Global Market under the ticker symbols “AMOD” (its common stock) and “AMODW” (its warrants) on Monday, December 16, 2024. About Alpha Modus Alpha Modus engages in creating, developing and licensing data-driven technologies to enhance consumers’ in-store digital experience at the point of decision. The company was founded in 2014 and is headquartered in Cornelius, North Carolina. For additional information, please visit alphamodus.com. About...

Continue reading

JCDecaux and JOJ Media House Group decide not to pursue the merger of their OOH activities in Slovakia

JCDecaux and JOJ Media House Group decide not to pursue the merger of their OOH activities in Slovakia Paris, December 13th, 2024 – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announced on December 14th, 2023 that it had signed an agreement regarding the merger of its activity in Slovakia with Akzent Bigboard, the outdoor advertising subsidiary of JOJ Media House Group, the leading Media Group in Slovakia. Finally, the parties have mutually agreed not to proceed with the transaction.    Key Figures for JCDecaux2023 revenue: €3,570.0m(a) – H1 2024 revenue: €1,807.6m(a) N°1 Out-of-Home Media company worldwide A daily audience of 850 million people in more than 80 countries 1,056,833 advertising panels worldwide Present in 3,918 cities with more than 10,000 inhabitants 11,650 employees JCDecaux...

Continue reading

Form 8.5 (EPT/RI) – Brand Architekts Group plc – AMENDMENT

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) Amendment – this form replaces the Rule 8.5 Disclosure published at 11:17am on 06/12/24. Changes have been made to Sections 2(a) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Brand Architekts Group plc(c)        Name of the party to the offer with which exempt principal trader is connected: Warpaint London Plc(d)        Date dealing undertaken: 05 December 2024(e)        Has the EPT previously disclosed, or is it today disclosing, under...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.